Modafinil treatment of pramipexole-associated somnolence.
Hauser
R A
RA
Department of Neurology, University of South Florida, Tampa General Hospital, USA.
Wahba
M N
MN
Zesiewicz
T A
TA
McDowell Anderson
W
W
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D052160:Benzothiazoles; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077408:Modafinil; D009290:Narcolepsy / Q000139:chemically induced* / Q000188:drug therapy*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D000077487:Pramipexole; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D001559:Benzhydryl Compounds; D052160:Benzothiazoles; D000697:Central Nervous System Stimulants; D013844:Thiazoles; D000077487:Pramipexole; D000077408:Modafinil